Showing results (31-40 of 161) with videos related to

Sort By:
Pageof 17
Archives of Gynecology and Obstetrics|June 30, 2017
Down-regulation of PARP1 by miR-891b sensitizes human breast cancer cells to alkylating chemotherapeutic drugsShujian Xu, Cui Zhao, Zhongming Jia, et al.
Translational Lung Cancer Research|May 19, 2025
Uniportal video-assisted thoracoscopic surgery does not increase recurrence rates following pneumonectomy in non-small cell lung cancer: a retrospective study from the National Cancer Center of ChinaSikai Wu, Xiaowei Chen, Guangyu Bai, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|August 9, 2024
Hypoxia-inducible factor-1α can reverse the Adriamycin resistance of breast cancer adjuvant chemotherapy by upregulating transferrin receptor and activating ferroptosisXiaojie Yu, Qingqun Guo, Haojie Zhang, et al.
Combinatorial Chemistry & High Throughput Screening|April 19, 2024
IL-7R Expression Correlates with Prognosis in Breast CancerXiaojie Yu, Hao Zhang, Jing Liu, et al.
Angewandte Chemie (International Ed. in English)|February 21, 2024
A Polymeric Nanoparticle to Co-Deliver Mitochondria-Targeting Peptides and Pt(IV) Prodrug: Toward High Loading Efficiency and Combination EfficacyJinpeng Yang, Zhenlin Yang, Hua Wang, et al.
Molecular Medicine Reports|April 16, 2016
Psoralen reverses the P-glycoprotein-mediated multidrug resistance in human breast cancer MCF-7/ADR cellsJingru Jiang, Xiaohong Wang, Kai Cheng, et al.
Clinical and Translational Medicine|April 21, 2026
The landscape of responses to neoadjuvant immunotherapy in resectable Kirsten rat sarcoma viral oncogene homolog-mutant lung adenocarcinoma: Clinical heterogeneity and correlative immunologic analysisSikai Wu, Jiheng Niu, Xiaowei Chen, et al.
Drug Delivery|August 12, 2025
Advances in oral treatment of inflammatory bowel disease using protein-based nanoparticle drug delivery systemsZhihao Lin, Ziheng Zhao, Xianrui Lin, et al.
Journal of Leukocyte Biology|July 22, 2025
An IL-15-modified NKp30×HER2 trispecific NK cell engager enhances NK cell activation and tumor cell killingYaping Cheng, Quanxiao Li, Yu Kong, et al.
Journal of Materials Chemistry. B|October 6, 2022
Boosting immunotherapy of triple negative breast cancer through the synergy of mild PTT and Fe-loaded organosilica nanoparticlesBen Yang, Hui Fu, Ronghua Kong, et al.
Pageof 17